Corrigendum to “IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas.” [Cancer Lett. 458C (2019) 29–38]

K. Mihajluk; C. Simms; M. Reay; P.A. Madureira; A. Howarth; P. Murray; S. Nasser; C.A. Duckworth; D.M. Pritchard; G.J. Pilkington; R. Hill

doi:10.1016/j.canlet.2019.10.002

Corrigendum to “IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas.” [Cancer Lett. 458C (2019) 29–38]

K. Mihajluk, C. Simms, M. Reay, P.A. Madureira, A. Howarth, P. Murray, S. Nasser, C.A. Duckworth, D.M. Pritchard, G.J. Pilkington, R. Hill

Institute of Life Sciences and Healthcare

University of Liverpool

Research output: Contribution to journal › Comment/debate › peer-review

180 Downloads (Pure)

Original language	English
Journal	Cancer Letters
DOIs	https://doi.org/10.1016/j.canlet.2019.10.002
Publication status	Early online - 8 Oct 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.canlet.2019.10.002

Corrigendum_to_IP1867B_suppresses_the_insulin_like_growth_factor_post_printAccepted author manuscript (Post-print), 487 KBLicence: CC BY-NC-ND

https://linkinghub.elsevier.com/retrieve/pii/S0304383519304938

1 Article

IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas
Mihajluk, K., Simms, C., Reay, M., Madureira, P. A., Howarth, A., Murray, P., Nasser, S., Duckworth, C. A., Pritchard, D. M., Pilkington, G. J. & Hill, R., 28 Aug 2019, In: Cancer Letters. 458, p. 29-38 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
382 Downloads (Pure)

Cite this

Mihajluk, K., Simms, C., Reay, M., Madureira, P. A., Howarth, A., Murray, P., Nasser, S., Duckworth, C. A., Pritchard, D. M., Pilkington, G. J., & Hill, R. (2019). Corrigendum to “IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas.” [Cancer Lett. 458C (2019) 29–38]. Cancer Letters. Advance online publication. https://doi.org/10.1016/j.canlet.2019.10.002

@article{17cc98fdd9674ef59ccc5f9596e81a94,

title = "Corrigendum to “IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas.” [Cancer Lett. 458C (2019) 29–38]",

author = "K. Mihajluk and C. Simms and M. Reay and P.A. Madureira and A. Howarth and P. Murray and S. Nasser and C.A. Duckworth and D.M. Pritchard and G.J. Pilkington and R. Hill",

year = "2019",

month = oct,

day = "8",

doi = "10.1016/j.canlet.2019.10.002",

language = "English",

journal = "Cancer Letters",

issn = "0304-3835",

publisher = "Elsevier Ireland Ltd",

}

Mihajluk, K, Simms, C, Reay, M, Madureira, PA, Howarth, A, Murray, P, Nasser, S, Duckworth, CA, Pritchard, DM, Pilkington, GJ & Hill, R 2019, 'Corrigendum to “IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas.” [Cancer Lett. 458C (2019) 29–38]', Cancer Letters. https://doi.org/10.1016/j.canlet.2019.10.002

TY - JOUR

T1 - Corrigendum to “IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas.” [Cancer Lett. 458C (2019) 29–38]

AU - Mihajluk, K.

AU - Simms, C.

AU - Reay, M.

AU - Madureira, P.A.

AU - Howarth, A.

AU - Murray, P.

AU - Nasser, S.

AU - Duckworth, C.A.

AU - Pritchard, D.M.

AU - Pilkington, G.J.

AU - Hill, R.

PY - 2019/10/8

Y1 - 2019/10/8

U2 - 10.1016/j.canlet.2019.10.002

DO - 10.1016/j.canlet.2019.10.002

M3 - Comment/debate

SN - 0304-3835

JO - Cancer Letters

JF - Cancer Letters

ER -